Search for: "People v. Actavis" Results 1 - 20 of 54
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Apr 2024, 11:27 am by admin
Another multi-district litigation (MDL) has hit a jarring speed bump. [read post]
5 Jul 2020, 5:43 am by Annsley Merelle Ward
  Surrounded by very intelligent people, I have always learned something I needed to know. [read post]
5 Jun 2020, 7:00 am by Andrew Hamm
The petitions of the week are below the jump: Actavis Holdco U.S. [read post]
19 Aug 2019, 9:20 am
Actavis Laboratories FL, Inc. [read post]
30 Apr 2019, 5:29 am
This focused on the three-step test of the Eli Lilly v Actavis UK Supreme Court decision and the subsequent UK cases applying that  test. [read post]
19 Dec 2018, 9:49 am
PatentsKat Neil reflects on the lexical transformation of the “troll” from stock character in Scandinavian mythology (and plastic dolls with bright colored up-combed hair...) into a staple of contemporary IP discourse, not once but twice: The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling"Kat Troll DollIPKat provided further depth commentary on Warner-Lambert v Actavis, delving… [read post]
27 Nov 2018, 3:19 am
The Supreme People’s Court of China ruling might be a game changer. [read post]
12 Jul 2018, 6:19 am by Brian Cordery
The Warner-Lambert v Actavis case concerning the drug pregabalin was heard by the Supreme Court in mid-February 2018 and considered, among other things, plausibility, infringement of second medical use patents and abuse of process. [read post]
14 May 2018, 12:30 pm
  Birss would not be drawn on his views of the Supreme Court's decision in Eli Lilly v Actavis (see the IPKat here - the 109 comments on the post is a good indication of how controversial this decision has been). [read post]
23 Mar 2018, 4:26 am
 PatentsActavis v ICOS - NetherlandsLast year, IPKat reported on the UK Court of Appeal decision Actavis v ICOS [2017] EWCA Civ 1671, in which the concept of "obvious to try" for a particular dosage regime was assessed in the context of clinical trial data. [read post]
1 Dec 2017, 6:20 am
The panel discussion was on the doctrine of equivalents following the Actavis v Lilly decision. [read post]
15 Aug 2016, 8:13 am by Michael Grossman
Demahy had pursued damages in a Louisiana venue against Actavis, Inc., another maker of the generic drug. [read post]
9 Jun 2016, 7:38 am by Rebecca Tushnet
  Not clear that people often approach design in that way. [read post]
22 Mar 2016, 4:00 am by Paula Bremner
People mistakenly think of health care as a utility they don’t pay for when in fact they do; education will stress the importance of low cost generics. [read post]
25 Jan 2016, 1:31 am
Some people think that the Enforcement Directive (2004/48/EC) is not working properly. [read post]